fluacizine fluacizine fluacizine, sold under the brand name phtorazisin, is a tricyclic antidepressant (tca) of the phenothiazine group which is or was marketed in russia. unlike other phenothiazines, fluacizine is not an antipsychotic, and can actually reverse catalepsy and extrapyramidal symptoms induced by antidopaminergic agents like antipsychotics, reserpine, and tetrabenazine as well as potentiate amphetamine-induced stereotypy. it is known to act as a norepinephrine reuptake inhibitor, antihistamine, and anticholinergic. the drug was developed in the 1960s and was marketed in the 1970s. it is the trifluoromethyl analogue of chloracizine. fluacizineclinical datatrade namesphtorazisinother namesfluoracizine; fluoracyzine; fluoracisine; ftoracizin; ftoracizine; phthoracizinroutes ofadministrationoral, intramuscular injectionatc codenonelegal statuslegal status in general: ℞ (prescription only) identifiers iupac name 3-diethylamino-1--propan-1-one cas number30223-48-4 y 27312-93-2 (hydrochloride)pubchem cid161562chemspider141910 yuniie2m3325b1rchemblchembl92281 ycomptox dashboard (epa)dtxsid2046175 chemical and physical dataformulac20h21f3n2osmolar mass394.46 g·mol−13d model (jsmol)interactive image smiles fc(f)(f)c2cc1n(c3c(sc1cc2)cccc3)c(=o)ccn(cc)cc inchi inchi=1s/c20h21f3n2os/c1-3-24(4-2)12-11-19(26)25-15-7-5-6-8-17(15)27-18-10-9-14(13-16(18)25)20(21,22)23/h5-10,13h,3-4,11-12h2,1-2h3 ykey:vheoujnddfhpgj-uhfffaoysa-n y (verify)